Latest News

Biotech Stocks Are Due to Bounce Back. Vertex Pharmaceuticals Stands Out.

0

Biotech stocks began the year in much the same way they ended it—by getting hammered. Vertex Pharmaceuticals, however, held its own, and that may be reason enough to start nibbling at its shares.

The sector had a terrible 2021. The iShares Biotechnology exchange-traded fund (ticker: IBB), which weights its holdings by market capitalization, rose 1%, its worst year since 2018, while the equal-weighted SPDR S&P Biotech ETF (XBI) fell 25%, its worst year since at least 2007. This year was supposed to be better, but so far it’s…

3 beaten-down Warren Buffett stocks poised to pop in 2022, if you’re looking for bargains amid all-time highs

Previous article

Bitcoin ETF Goes From Boom to Bust After a Record U.S. Debut

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News